Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
investing
4
×
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
autoimmune diseases
biotech ipos
bridgebio
bristol-myers squibb
chronic kidney disease
deals
immunotherapy
What
new
4
×
life
science
bio
companies
ipo
market
momentum
raised
roundup
week
advantages
arrival
bails
bar
biotech
biotechs
brand
bridgebio
brings
capital
car
club
continued
crop
days
develop
drug
drugs
emerges
exceeded
expect
firm
firms
gamble
grab
group
hasn’t
haul
headlines
Language
unset
Current search:
national
×
biotech
×
new
×
investing
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M